{"name":"Pamlab, Inc.","slug":"pamlab-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOOGtzUHNmN0hwalJEWHY5a0xxT0d6ajNSWU9DZTQ0Y2p0Z2piSExIN0pYTmNMUS14YWx2WmpUVVA0ekVyejlKc2diRHdSd3VFTW5MbUlTN3FKSzc4STJFenA5R1RLbDY2MUhSLVZrUjkyUXRPUXR5VXUzR2wxOVBjOWNaVmpRVVVjLTZhdEJHSjNfSmJwVFpPM0p1aFVhWU9yWmNvaXRFOWd1aUpY?oc=5","date":"2025-06-09","type":"pipeline","source":"Medscape Reference","summary":"Addressing Partial Treatment Response in MDD Patients - Medscape Reference","headline":"Addressing Partial Treatment Response in MDD Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPZDh1VnlFQlJIYVBtX2VzLTV5VjJ2SzZYNkdXbnBsZ1BLQk9vWEprYmpLbTN4dzRnaG92aC16X2NTVVpCWjF1cEZ6MTE3WGR2dkJ1YW42Q2tHS3RGMnMtWldWQ3duc3BCRk5mZnRuLWtIMjdaVGlmSlp4S0RjNWQ5Yk9IUFZjaFpo?oc=5","date":"2024-09-12","type":"pipeline","source":"SupplySide Supplement Journal","summary":"Medical Foods: Between a Rock and a Hard Place - SupplySide Supplement Journal","headline":"Medical Foods: Between a Rock and a Hard Place","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9TcWZTV1hpdU11dDdrNEN2MVpOejNUdU85cjlfbF9ad2hrUk41REhPanV3T0x3b05CR1pGYWFDcmd5SWNvVlJhWVBUNVF2cDd4eWY0ci1VbTVjelc2RnFv?oc=5","date":"2024-03-07","type":"trial","source":"Nature","summary":"Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial | Molecular Psychiatry - Natur","headline":"Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depre","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOZktDTlM4Nk1yU1A0R2RTNjEwMXZHZ1JjbzlURUV2X0s5bzA4RGhYNncwdzFxZm9kUHB2cHM2UjhUMzgzRk8tWE9GdnlLLUdoTm10eEhQSlNXYVRZQlpJZ2V6V3pWY0RlU0RjdUVTSVJUZmNabGxDVFpNZmdqMDh3dGFLbWRqbFNQQ3psak5WNA?oc=5","date":"2024-02-01","type":"pipeline","source":"Frontiers","summary":"Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major Depression - Frontiers","headline":"Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE5vZFgyYldwZ0tWUHFwaVF0OW01c0xQZWc0dzVLNVp5NUpxUHhXN09UZWlJTVZqaUJaR0FPV0Z3TUhhMGdWUUpWdmlHNEc2eGl1YkQxX3ZVbDdubUxrRFE?oc=5","date":"2020-01-27","type":"regulatory","source":"Nature","summary":"Success and efficiency of phase 2/3 adjunctive trials for MDD funded by industry: a systematic review - Nature","headline":"Success and efficiency of phase 2/3 adjunctive trials for MDD funded by industry: a systematic review","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNZVc2UXdVOVBZTTFJNmlPekdOd2FTb0ZuWGhBT0Uyb2txYXl2MjBTSzljYkdBbFB6WkZnR1lOd09wOXBNcnFVMGM0RTktZWZfREJrQkxlQTlnLWVhOTFsVFZGeWJJekwxR3NIUXJyNlJWWXFoTkxDZjBDX3FGZ1EtYUE3SUl0dFF0SXBRWkptcmxacENodFNhQ0lGdU9TSVQweklsOXRSbTVIekw2?oc=5","date":"2017-07-28","type":"pipeline","source":"Food Dive","summary":"Plant-based food firm Daiya bought for $325.97M by pharma company Otsuka - Food Dive","headline":"Plant-based food firm Daiya bought for $325.97M by pharma company Otsuka","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE51Qi1ucVNPU1pJdnRwdzFybHBSdGE0MDhYOFgzZDRYV08xOGVMeVZ0Y0ZzS0wyRldOTlN6YWJZdFFNRHZZSS1jbjU2UVl4bDl0QTRvRGFlS3dOZTAwck5reU55VWZGNXVVMTZlS1Zn?oc=5","date":"2013-03-04","type":"deal","source":"Nestlé USA","summary":"Nestlé Health Science Acquires Pamlab in the US - Nestlé USA","headline":"Nestlé Health Science Acquires Pamlab in the US - Nestlé USA","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}